Moderna sues Pfizer and BioNTech for alleged mRNA vaccine patent infringement

Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology Moderna developed years before the pandemic. The lawsuit, which seeks indeterminate damages, was filed in the U.S. District Court in Massachusetts and the Düsseldorf Regional Court


Modern (MRNA) Q2 2022

Illustration of a vial of Moderna vaccine for the treatment of coronavirus. Marcos Del Mazo | Light flare | Getty Images modern announced second-quarter results on Wednesday that beat expectations for earnings and revenue, which generated $4.5 billion in sales of its Covid-19 vaccine, but it is still the only product available in the company’s